A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma

Author： Kuna P.   Joubert J.R.   Greefhorst L.A.P.M.   Magnussen H.  

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.10, 2003-10, pp. : 2634-2634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy and Safety of Desloratadine in Adults with Chronic Idiopathic Urticaria: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

By Ortonne Jean-Paul  

American Journal of Clinical Dermatology, Vol. 8, Iss. 1, 2007-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst study

By Malacco E.   Vari N.   Capuano V.   Spagnuolo V.   Borgnino C.   Palatini P.   Val-Syst Investigators  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2765-2780

Elsevier

Access to resources Recommend Favorite

Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study

By Castano G.   Mas R.   Fernandez J.   Lopez E.   Illnait J.   Fernandez L.   Mesa M.  

Current Therapeutic Research, Vol. 64, Iss. 8, 2003-09 ,pp. : 522-537

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

By Davidson M.H.   Palmisano J.   Wilson H.   Liss C.   Dicklin M.R.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2738-2753

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

By Kimball Alexa B.  

American Journal of Clinical Dermatology, Vol. 12, Iss. 1, 2011-02 ,pp. : 51-62

Adis International

Access to resources Recommend Favorite